The combinations of eight first-line antibiotics were investigated against S. aureus and P. aeruginosa by the evaluation of fractional inhibitory concentration (FIC) index. Ten isolates of S. aureus and ten isolates of P. aeruginosa were isolated from clinical samples and the minimum inhibitory concentration (MIC) for each antibiotic was determined. Synergistic interactions were observed in the combinations ampicillin-gentamycin, rifampicin-neomycin and rifampicintetracycline against both S. aureus and P. aeruginosa; and also in ciprofloxacin-tobramycin for P. aeruginosa. Other combinations were either additive or indifferent; one antagonistic interaction between chloramphinicol-erythromycin was observed. The results suggest that antibiotic combination is a potential way to achieve synergy when the causal organism is a multi-antibiotic resistance one.
Introduction
The wide use of antibiotics in the treatment of bacterial infections has led to the emergence and spread of resistant strains. Infections due to Staphylococcus are resistant to beta-lactam [1] . While Enterococcus strains are resistant to vancomycin, ampicillin, gentamycin and streptomycin [2] . Gram negative pathogens such as Salmonella species, Pseudomonas aeruginosa and Klebsiella pneumonia have become multidrug resistant [3] . Among the various infections caused by bacteria, antibiotic resistant ones are of major concern because of their non-responsiveness to treatment with a single drug regime thus resulting in therapeutic failure [4] . The use of antibiotic combinations has been known since a long time and is often applied when several mechanisms of action and toxicity profile of agents involved can be brought to halt at once [5] . The biocidal (bacteriocidal, fungicidal or virucidal) activity could be best achieved by the combination of two different antibiotics rather than the effect obtained by an individual antibiotic [6] . Antimicrobial synergism occur when two or more antibiotics, in combination exert an inhibitory effect that is greater than the additive effects of the individual antibiotic [7] . The reason to apply more than one antibiotic is to increase the activity of the antibiotic, decrease the side effect of some antibiotics and reduce the dose when situations of resistance development and ineffectiveness of single antibiotic are prevalent in the treatment of inflammatory infections that are life threatening [8] .
Combinations of antimicrobials that demonstrate an in vitro synergism against infecting strains are more likely to result in successful therapeutic outcome [9] . Thus there is a need to find new ways to control evolving of drug resistant infections [11] .
Among the methods employed in the evaluation of the combination of two antimicrobials potentially exhibiting synergism is the checkerboard or fractional inhibitory concentration (FIC) index. FIC employs a methodology similar to that utilized for the determination of the minimum inhibitory concentration (MIC). The combination is said to have synergistic effect if there is a 4-fold reduction in the MIC for each antimicrobial agent tested alone [11] .
The purpose of this study is to investigate antimicrobial activity and evaluate the interaction of various combination of antibiotics against S. aurous and P. aeruginosa using the FIC index method. It is thought that the results may provide rational basis for clinical use of these combinations against infections caused by these drug resistant organisms.
Materials and Methods

Samples Collection
Samples were collected from wound and post operative infection (POI) of patients hospitalized in various Baghdad hospitals. From these samples 11 isolates of S. aureus and 11 isolates P. aeruginosa were included and these were identified depending on their morphological and biochemical tests as compared with the identification scheme described by Holt et al. (1994) [12] .
Preparation of Bacterial Inoculum
The inoculum of the test organisms were prepared using the colony suspension [13] . Colonies picked from 24 h old culture grown on nutrient agar were used to make suspension of the test organisms in normal saline (NS) to give an optical density of approximately 1.1 at 611 nm. The suspension was then diluted 10111 by transfer 1.1 ml of the bacterial suspension to 9.9 ml of sterile nutrient broth (NB) before use.
The following antibiotics were used in this study. Ampicillin 511 mg (SDI, Iraq), Chloramphinicol 511 mg (Bavaria Pharma, Germany), Ciprofloxacin 511 mg (Remedica, Cyprus), Erythromycin 251 mg (ZetaBoard, India), Gentamicin 211 mg (Morvel, India), Levofloxacin 511 mg(Sandoz, USA), Neomycin 511 mg (Sandoz, USA), Rifampicin 511 mg (Lannett, USA), Tetracycline 251 mg (Actavis, USA), Tobramycin 511 mg (Novaplus, Austria).
Determination of the Minimum Inhibitory Concentrations (MIC) (Tube dilution assay)
To determine the minimum inhibitory concentrations, the antibiotic was dissolved in distilled water (DW) to give stock concentration of 512 μg/ml. Two fold serial dilutions of the antibiotics were made to give concentrations ranging from 1.5 to 512 μg/ml. One hundred micro liter of bacterial inoculum was added to the dilution tubes. The tubes were incubated at 37 ºC for 24h under aerobic conditions. The MIC was defined as the lowest concentration of the antibiotic that completely inhibited visible growth of the organism as observed with naked eye [14] .
Determination of Interaction between antibiotics
The study of the combined antimicrobial activity of antibiotics was done by broth dilution checkerboard method as described by Mandal et al. (2114) [15] . The antibiotics were combined at concentrations ranging from 1/8 x MIC to 2xMIC, then inoculated with bacterial cultures and incubated for 24h at 37 ºC after which the MIC values were estimated. The fractional inhibitory concentration (FIC) was derived from the lowest concentration of antibiotic combination permitting no visible growth of the test organism in the tube and was calculated for each antimicrobial concentration as follows: Combination between antibiotics according to accepted criteria [16] as follows: ≤ 1.5, synergy; 1.5 to 1.1, additive; 1.1 to 4.1, indifference; and > 4, antagonism.
Results and Discussion
The tube dilution assay (MIC test) for the inhibitory effect of the antibiotic alone for S. aureus and P. aeruginosa are shown in Table (1) . The results are obtained from ten isolates of each organism. The antibiotics used in this study appeared to vary in the levels of susceptibility to S. aureus and P. aeruginosa. Most of the antibiotics were effective against S. aureus except ampicillin, in comparison with P. aeruginosa, which is less susceptible to ampicillin, chloramphinicol, erythromycin, and tetracycline. A relationship is suggested between the MIC of an antimicrobial and clinical outcome of infections due to S. aureus and P. aeruginosa treated with single antimicrobial [17] . In particular, a lower MIC was associated with a faster healing response [18] .
It is reasonable to assume that the lower the MIC of an antimicrobial for a given isolate, the more likely it is that the infection will respond to treatment and that the MIC of the antimicrobial can be used to evaluate the potency of a given agent.
In the checkerboard method, the interaction between selected combinations of the eight antibiotics against 11 isolates of each of S. aureus and P. aeruginosa as estimated by the mean FIC index values and standard deviation (SD) are shown in Table ( 2) for S. aureus and P. aeruginosa.
Synergistic reactions are seen in the combinations ampicillin-gentamycin mean FIC index 1.4, rifampicin-neomycin mean FIC index 1.34 and rifampicin-tetracycline mean FIC index 1.45 for S. aureus, and ampicillin-gentamycin mean FIC index 1.41, ciprofloxacin -tobramycin mean FIC index 1.44, rifampicin-neomycin mean FIC index 1.35 and rifampicin-tetracycline mean FIC index 1.39 for P. aeruginosa. Other combinations were either additive or indifferent.
Only one combination chloramphinicol-erythromycin was antagonist against S. aureus. The combination ampicillin -gentamycin is synergetic against both S. aureus and P. aeruginosa as a result of ampicillin which is known as an agent of β-lactam block enzyme of transpeptidase needed by the bacteria to make their cell wall, while gentamicin is known to inhibit protein synthesis by binding to the 31s ribosomal subunit. The result of this combination is inline with the work of Kim et al. (2119) [19] , who demonstrated that ampicillin-gentamycin can act synergistically in inhibiting methicillin -resistant S. aurues (MRSA) in vitro.
The synergy in the combination ciprofloxacin -tobramycin is explained by the action of ciprofloxacin which is known to block DNA synthesis by inhibiting one of the enzymes (DNA gyrase) needed in this process and the action of tobramycin which is known to work by binding to a site on the bacterial 31s and 51s ribosome by preventing the formation of 71s complex. Our results are compatible with the report of NcNabb et al., (2111) [21] that explained the superior activity of ciprofloxacin against P. aeruginosa in combination with ceflazidime that yield remarkable activity profile.
The combinations rifampicin -neomycin and rifampicin -tetracycline also indicate synergism against both S. aureus and P. aeruginosa, since rifampicin is commonly used in the treatment of staphellococcual prosthesis or skin associated infection, including chronic wound [21] . The chemical structure of rifampicillin allows the drug to penetrate the wall into tissue and abscesses, while are poorly penetrated by rest other antistaphylococcal agents [22] . However, S. aureus can develop rifampicin resistance during a single passage [23] , and it is therefore always used in combination with other antibiotics to treat bacterial infection [24] . In fact, the combination rifampicin -minocycline (tetracycline) has been found to have an efficiency of 717 in rabbit model [25] . The synergistic activity of rifampicin -neomycin against S. aureus and P. aeruginosa is in agreement with the report of Bisdas et al., (2112) [26] that rifampicin -neomycin showed excellent in vitro antibiotical activity against both gram-positive and gram-negative pathogens representing an effective candidate for vascular graft impregnation. Fig.(1) shows analogy -variance activity of the combined antibiotics against S. aureus and P. aeruginosa for synergy, additive-indifference and antagonistic reactions. It is interesting to note that infections with Staphylococcus or Pseudomonas species are notoriously difficult to treat as both organisms exhibit resistance to multiantibiotic; few new antibiotics are currently in development [27] . It has also been shown that combination of antibiotic with non-antibiotic substance can enhance the efficiency of a number of currently used antibiotics by forming synergistic combinations [28] .
Conclusion
The combinations ampicillin-gentamycin, rifampicin-neomycin and rifampicintetracycline gave the lowest mean FIC index for S. aureus indicative of synergitical effect in 857. Against P. aeruginosa the combinations ampicillin -gentamycin, ciprofloxacin-tobramycin as well as rifampici-neomycin and rifampicintetracycline also gave lowest mean FIC index indicative of synergy in 817. Only one combination chloramphinicol -erythromycin was consistently antagonistic when used against S. aureus. Other combinations tested were predominately additive or indifferent. An elucidation of the mechanisms of action of these compounds need to be followed by toxicity and in vivo tests to determine the therapeutic applicability of such compounds in combination therapy.
